journal article·2013-10

Dual Acid‐Responsive Micelle‐Forming Anticancer Polymers as New Anticancer Therapeutics

Byungkuk Kim, Eunsun Lee, Yerang Kim, Sanga Park, Gilson Khang, Dongwon Lee

Advanced Functional Materials· Volume 23· Issue 40
Publisher page

Abstract

Cinnamaldehyde, a major active compound of cinnamon, is known to induce apoptotic cell death in numerous human cancer cells. Here, dual acid‐responsive polymeric micelle‐forming cinnamaldehyde prodrugs, poly[(3‐phenylprop‐2‐ene‐1,1‐diyl)bis(oxy)bis(ethane‐2,1‐diyl)diacrylate]‐co‐4,4’(trimethylene dipiperidine)‐co‐poly(ethylene glycol), termed PCAE copolymers, are reported. PCAE is designed to incorporate cinnamaldehyde via acid‐cleavable acetal linkages in its pH‐sensitive hydrophobic backbone and self assemble to form stable micelles which can encapsulate camptothecin (CPT). PCAE self assembles to form micelles which release CPT and cinnamaldehyde in pH‐dependent manners. PCAE micelles induce apoptotic cell death through the generation of intracellular reactive oxygen species (ROS) and exert synergistic anticancer effects with a payload of CPT in vitro and in vivo model of SW620 human colon tumor‐bearing mice. It is anticipated that dual acid‐sensitive micelle‐forming PCAE with intrinsic anticancer activities has enormous potential as novel anticancer therapeutics.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of BIN Fusion Technology Chonbuk National University Jeonju Chonbuk 561‐756 Korea

Polymer Fusion Research Center, Department of Polymer·Nano Science and Technology Chonbuk National University Jeonju Chonbuk 561‐756 Korea

References (32)

Show source-provided references
1. 10.1016/j.tibtech.2005.11.00610.1016/j.tibtech.2005.11.006 ↗
2. 10.1007/s11095-010-0233-410.1007/s11095-010-0233-4 ↗
3. 10.1074/jbc.M30970820010.1074/jbc.M309708200 ↗
4. Palmer H. J. · Nat. Rev. · 1997 · 55 · 353
5. 10.1016/S0003-9861(02)00053-X10.1016/S0003-9861(02)00053-X ↗
6. 10.1016/S0014-5793(98)01410-010.1016/S0014-5793(98)01410-0 ↗
7. 10.1074/jbc.273.41.2690010.1074/jbc.273.41.26900 ↗
8. 10.1023/A:100961622830410.1023/A:1009616228304 ↗
9. 10.1016/j.freeradbiomed.2008.10.02510.1016/j.freeradbiomed.2008.10.025 ↗
10. 10.1016/j.freeradbiomed.2009.10.02810.1016/j.freeradbiomed.2009.10.028 ↗
11. 10.1016/j.bbrc.2009.07.10410.1016/j.bbrc.2009.07.104 ↗
12. 10.1016/j.foodchem.2006.08.01810.1016/j.foodchem.2006.08.018 ↗
13. 10.1016/S0304-3835(03)00238-610.1016/S0304-3835(03)00238-6 ↗
14. 10.1016/j.addr.2004.10.00610.1016/j.addr.2004.10.006 ↗
15. 10.1080/0049825080265006910.1080/00498250802650069 ↗
16. 10.1016/S0142-9612(00)00073-910.1016/S0142-9612(00)00073-9 ↗
17. 10.1002/marc.20090002910.1002/marc.200900029 ↗
18. 10.1002/adfm.20090083910.1002/adfm.200900839 ↗
19. 10.1021/nn100968e10.1021/nn100968e ↗
20. 10.1039/c0cc01413c10.1039/c0cc01413c ↗
21. 10.1021/ja001538810.1021/ja0015388 ↗
22. 10.1039/B304251K10.1039/B304251K ↗
23. 10.1073/pnas.093064410010.1073/pnas.0930644100 ↗
24. 10.1021/ma00125a04010.1021/ma00125a040 ↗
25. 10.1002/adfm.20060081810.1002/adfm.200600818 ↗
26. 10.1016/j.jconrel.2007.07.01210.1016/j.jconrel.2007.07.012 ↗
27. 10.1016/j.jconrel.2010.02.02410.1016/j.jconrel.2010.02.024 ↗
28. 10.1016/j.biomaterials.2010.11.03310.1016/j.biomaterials.2010.11.033 ↗
29. 10.1038/sj.cdd.440143510.1038/sj.cdd.4401435 ↗
30. 10.1016/j.ejpb.2010.04.01710.1016/j.ejpb.2010.04.017 ↗
31. 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R ↗
32. 10.1158/1078-0432.CCR-06-078610.1158/1078-0432.CCR-06-0786 ↗